生物製药市场规模、份额、成长分析（按类型、分销管道、应用和地区）—2025 年至 2032 年产业预测

预计生物製药市场规模将在 2023 年达到 5,703 亿美元，从 2024 年的 6,085.1 亿美元成长到 2032 年的 1,2,231 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.7%。

根据市场洞察，由于全球人口增长以及与老龄化相关的疾病和慢性疾病的增加，对生物製药的需求正在增长。世界卫生组织 (WHO) 预测，到 2020 年，65 岁及以上成年人的数量将超过 5 岁以下儿童的数量，到 2050 年这一趋势也将保持不变。这种人口结构变化增加了对医疗保健服务的需求，以管理癌症、神经系统疾病和心血管疾病等老年人中普遍存在的疾病。家庭和专业护理需求的不断增长进一步扩大了这种需求，并鼓励生物製药公司在研发方面投入更多资金。此外，生物製药监管部门的核准不断增加，有望加快创新治疗方法的获取，这将在未来几年显着推动市场成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

生物製药市场规模（按类型及复合年增长率） (2025-2032)

• 市场概览
• 免疫调节药物
  • 单株抗体
  • 细胞激素
  • 干扰素
  • 其他的
• 酵素
  • 水解酶
  • 解离酶
  • 氧化还原酶
  • 其他的
• 疫苗
  • 重组/复合物/次单元
  • 惰性
  • 减毒活疫苗
  • 类毒素
• 荷尔蒙
  • 人体生长荷尔蒙
  • 胰岛素
  • 甲状腺刺激素
  • 其他的
• 其他的

生物製药市场规模（依通路划分）及复合年增长率（2025-2032）

• 市场概览
• 医院药房
• 药局和药房
• 网路药局

生物製药市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概览
• 心臟病学
• 肿瘤学
• 呼吸系统
• 免疫学
• 神经病学
• 其他的

生物製药市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Lonza Group（Switzerland）
• WuXi Biologics（China）
• Fujifilm Diosynth Biotechnologies（Japan）
• Recipharm（Sweden）
• Samsung Biologics（South Korea）
• Boehringer Ingelheim（Germany）
• Catalent（USA）
• Thermo Fisher Scientific（USA）
• Siegfried Holding AG（Switzerland）
• AGC Biologics（Japan）
• WuXi AppTec（China）
• Cambrex Corporation（USA）
• Charles River Laboratories（USA）
• Chugai Pharmaceutical（Japan）
• Biocon Limited（India）
• Dr. Reddy's Laboratories（India）
• Sun Pharmaceutical Industries（India）
• Teva Pharmaceutical Industries（Israel）
• Novartis（Switzerland）

结论和建议

Biopharmaceuticals Market size was valued at USD 570.3 billion in 2023 and is poised to grow from USD 608.51 billion in 2024 to USD 1022.31 billion by 2032, growing at a CAGR of 6.7% during the forecast period (2025-2032).

Market insights reveal a growing demand for biopharmaceuticals, driven by an increasing global population coupled with a rise in age-related diseases and chronic medical conditions. The World Health Organization notes that in 2020, adults aged 65 and older outnumbered children under five, a trend expected to equalize by 2050. This demographic shift is prompting heightened demand for healthcare services, particularly to manage disorders like cancer, neurological conditions, and cardiovascular diseases prevalent among seniors. The rising need for both family and professional care further amplifies this demand, encouraging biopharmaceutical companies to boost investments in research and development. Additionally, an uptick in regulatory approvals for biopharmaceutical products promises expedited access to innovative treatments, significantly propelling the market's growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biopharmaceuticals market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biopharmaceuticals Market Segments Analysis

Global Biopharmaceuticals Market is segmented by Type, Distribution Channel, Application and region. Based on Type, the market is segmented into Immunomodulators, Enzymes, Vaccines, Hormones and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Pharmacies. Based on Application, the market is segmented into Cardiology, Oncology, Respiratory, Immunology, Neurology and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biopharmaceuticals Market

A significant driver fueling the growth of the biopharmaceuticals market is the escalating prevalence of chronic diseases worldwide. This alarming rise has prompted governments across various regions to initiate awareness campaigns aimed at educating the public about these conditions, resulting in a heightened focus on treatment options. Consequently, the demand for medications in the biopharmaceutical sector, particularly those targeting specialized areas such as rare, chronic, and hereditary disorders, is expected to see a steady increase. As more individuals become aware of their healthcare options, the market is poised for substantial expansion, driven by the need for effective therapeutic solutions.

Restraints in the Biopharmaceuticals Market

The biopharmaceuticals market faces significant restraints due to the elevated costs associated with development and production. The complex manufacturing processes and stringent regulatory requirements necessitate advanced technologies, resulting in the higher overall expense of biologics. This inflated cost can create barriers to access and limit affordability for numerous patients and healthcare systems. Consequently, the financial challenges linked to the development and formulation of biopharmaceuticals mean that many individuals may not benefit from these innovative therapies, ultimately hindering the market's growth and restricting patient access to essential treatments.

Market Trends of the Biopharmaceuticals Market

The biopharmaceutical market is witnessing a transformative trend in gene and cell therapies, which address pressing healthcare needs, particularly for rare diseases, cancers, and genetic disorders. These innovative therapies are ushering in a new era of personalized medicine, offering potential curative solutions through targeted cell or DNA replacement. The efficacy of these treatments is bolstered by breakthroughs in viral vector delivery systems and CRISPR technology, enhancing precision and outcomes. However, challenges related to high costs and navigating regulatory approvals remain prominent. As research and development efforts continue, the market is anticipated to expand significantly, revolutionizing patient care and treatment paradigms.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Biopharmaceuticals Market Size by Type & CAGR (2025-2032)

• Market Overview
• Immunomodulators
  • Monoclonal Antibodies
  • Cytokines
  • Interferons
  • Others
• Enzymes
  • Hyrdolases
  • Lyases
  • Oxidoreductases
  • Others
• Vaccines
  • Recombinant/Conjugate/Subunit
  • Inactivated
  • Live Attenuated
  • Toxoid
• Hormones
  • Human Growth Hormones
  • Insulin
  • Thyroid Stimulating Hormones
  • Others
• Others

Global Biopharmaceuticals Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies

Global Biopharmaceuticals Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiology
• Oncology
• Respiratory
• Immunology
• Neurology
• Others

Global Biopharmaceuticals Market Size & CAGR (2025-2032)

• North America (Type, Distribution Channel, Application)
  • US
  • Canada
• Europe (Type, Distribution Channel, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Distribution Channel, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Distribution Channel, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Distribution Channel, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi Biologics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Diosynth Biotechnologies (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recipharm (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siegfried Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AGC Biologics (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chugai Pharmaceutical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations